Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.100
-0.050 (-2.33%)
At close: Jun 24, 2026, 4:00 PM EDT
2.111
+0.011 (0.50%)
After-hours: Jun 24, 2026, 7:56 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $121.59 million as of June 24, 2026. Its market cap has decreased by -21.20% in one year.
Market Cap
121.59M
Enterprise Value
67.94M
1-Year Change
-21.20%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $121.59M, a decrease of -21.09%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 121.59M | -7.39% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 134.95M |
| Genelux | 134.11M |
| ADC Therapeutics | 133.55M |
| PepGen | 133.50M |
| NeOnc Technologies Holdings | 130.28M |
| Fractyl Health | 128.98M |
| Connect Biopharma Holdings | 127.50M |
| Aldeyra Therapeutics | 126.98M |